Anti-BRAF35 antibody
-
概述
- 产品描述Required for correct progression through G2 phase of the cell cycle and entry into mitosis. Required for RCOR1/CoREST mediated repression of neuronal specific gene promoters. sequence caution:Translation N-terminally extended. Contains 1 HMG box DNA-binding domain. subcellular location:Localized to condensed chromosomes in mitosis in conjunction with BRCA2. subunit:Component of a BHC histone deacetylase complex that contains HDAC1, HDAC2, HMG20B/BRAF35, AOF2/LSD1, RCOR1/CoREST and PHF21A/BHC80. The BHC complex may also contain ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I. Interacts with the BRCA2 tumor suppressor protein. tissue specificity:Ubiquitously expressed in adult tissues.
- 产品名称Anti-BRAF35 antibody
- 分子量36 kDa
- 种属反应性Human
- 验证应用WB, IHC-P, IF
- 抗体类型兔多抗
- 免疫原The antiserum was produced against synthesized peptide derived from human HMG20B. AA range:1-50
- 偶联Non-conjugated
-
性能
- 形态Liquid
- 浓度1 mg/mL.
- 存放说明Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
- 存储缓冲液Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 亚型IgG
- 纯化方式Immunogen affinity purified.
- 其它名称HMG20B antibody; BRAF35 antibody; HMGX2 antibody; HMGXB2 antibody; SMARCE1R antibody; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related antibody; SMARCE1-related protein antibody; BRCA2-associated factor 35 antibody; HMG box-containing protein 20B antibody; HMG domain- antibody;
-
应用
WB: 1:500-1:2000
IHC-P: 1:100-1:300
IF: 1:100-1:500
-
Fig1: Western Blot analysis of various cells using BRAF35 Polyclonal Antibody diluted at 1：2000 cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit (SC-003,Inventbiotech,MN,USA).
特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
